The U.S. Department of Justice (DOJ) and other government enforcers announced a number of key settlements in the life sciences industry in October – December 2019. These settlements include:
| LIFE SCIENCES INDIVIDUALS/ ENTITIES | SETTLEMENT DATE | RESOLUTION | KEY AREAS OF ENFORCEMENT |
| Pharmaceutical company | Dec. 3, 2019 | $3 million
Deferred prosecution agreement Restitution |
|
| Charitable foundation | Nov. 20, 2019 | $4 million
Three year integrity agreement |
|
| Medical device company | Nov. 7, 2019 | $5.99 million |
|
| Pharmaceutical supplier | Nov. 7, 2019 | $22.05 million |
|
| Two charitable foundations | Oct. 25, 2019 | $4 million
$2 million Three-year integrity agreements |
|
| Genetic testing company | Oct. 9, 2019 | $42.6 million
Exclusion |
|
These settlements demonstrate the continued importance for life sciences companies to monitor industry developments and determine ways in which to improve their corporate compliance programs.
